5-HT2 receptor regulation of mitochondrial genes: Unexpected pharmacological effects of agonists and antagonists

Journal of Pharmacology and Experimental Therapeutics

Volumn 357, Issue 1, 2016, Pages 1-9

  Harmon, Jennifer L ^a   Wills, Lauren P ^a   McOmish, Caitlin E ^b,c   Demireva, Elena Y ^b,d   Gingrich, Jay A ^b,d   Beeson, Craig C ^a   Schnellmann, Rick G ^a,e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e Veterans Administration   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6-CHLORO-5-METHYL-1-((2-(2-METHYLPYRID-3-YLOXY)PYRID-5-YL)CARBAMOYL)INDOLINE; AMINOPYRIDINE DERIVATIVE; CP-809,101; INDOLE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PIPERAZINE DERIVATIVE; PPARGC1A PROTEIN, MOUSE; PYRAZINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; KIDNEY PROXIMAL TUBULE; MALE; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; RABBIT; TRANSGENIC MOUSE;

AMINOPYRIDINES; ANIMALS; ELECTRON TRANSPORT COMPLEX I; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INDOLES; KIDNEY TUBULES, PROXIMAL; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; PIPERAZINES; PYRAZINES; RABBITS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN 5-HT2 RECEPTOR AGONISTS; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; TRANSCRIPTION FACTORS;

EID: 84962533050     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.115.228395     Document Type: Article

References (44)

1. Abramowski D and Staufenbiel M (1995) Identification of the 5-hydroxytryptamine2C receptor as a 60-kDa N-glycosylated protein in choroid plexus and hippocampus. J Neurochem 65:782-790.
2. Alexander SP, Mathie A, and Peters JA (2008) Guide to receptors and channels (GRAC), 3rd edition. Br J Pharmacol 153(Suppl 2):S1-S209.
3. Ballinger SW (2005) Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 38:1278-1295.
4. Beeson CC, Beeson GC, and Schnellmann RG (2010) A high-throughput respirometric assay for mitochondrial biogenesis and toxicity. Anal Biochem 404:75-81.
5. Bromidge SM, Duckworth M, Forbes IT, Ham P, King FD, Thewlis KM, Blaney FE, Naylor CB, Blackburn TP, and Kennett GA, et al. (1997) 6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl) oxy]-5-pyridyl]carbamoyl]-indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist. J Med Chem 40:3494-3496.
6. Butterfield DA, Howard BJ, and La Fontaine MA (2001) Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease. Curr Med Chem 8:815-828.
7. Chen SD, Yang DI, Lin TK, Shaw FZ, Liou CW, and Chuang YC (2011) Roles of oxidative stress, apoptosis, PGC-1a and mitochondrial biogenesis in cerebral ischemia. Int J Mol Sci 12:7199-7215.
8. Da Cruz S, Parone PA, Lopes VS, Lillo C, McAlonis-Downes M, Lee SK, Vetto AP, Petrosyan S, Marsala M, and Murphy AN, et al. (2012) Elevated PGC-1a activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab 15:778-786.
9. Dulawa SC and Geyer MA (2000) Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39:2170-2179.
10. Feldkamp T, Kribben A, and Weinberg JM (2005) Assessment of mitochondrial membrane potential in proximal tubules after hypoxia-reoxygenation. Am J Physiol Renal Physiol 288:F1092-F1102.
11. Funk JA and Schnellmann RG (2012) Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am J Physiol Renal Physiol 302:F853-F864.
12. Garnovskaya MN, Nebigil CG, Arthur JM, Spurney RF, and Raymond JR (1995) 5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation. Mol Pharmacol 48:230-237.
13. Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, and Kristensen JL (2014) Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. ACS Chem Neurosci 5:243-249.
14. Herrick-Davis K, Grinde E, Lindsley T, Teitler M, Mancia F, Cowan A, and Mazurkiewicz JE (2015) Native serotonin 5-HT2C receptors are expressed as homodimers on the apical surface of choroid plexus epithelial cells. Mol Pharmacol 87:660-673.
15. Jaeschke H, McGill MR, and Ramachandran A (2012) Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 44:88-106.
16. Kelly DP and Scarpulla RC (2004) Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 18:357-368.
17. Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, and Bromidge S, et al. (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609-620.
18. Kilkenny C, Browne W, Cuthill IC, Emerson M, and Altman DG; NC3Rs Reporting Guidelines Working Group (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160:1577-1579.
19. Killam AL, Nikam SS, Lambert GM, Martin AR, and Nelson DL (1990) Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity. J Pharmacol Exp Ther 252:1083-1089.
20. Lifshitz J, Sullivan PG, Hovda DA, Wieloch T, and McIntosh TK (2004) Mitochondrial damage and dysfunction in traumatic brain injury. Mitochondrion 4:705-713.
21. Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, Kump DS, Hachey DL, Roth BL, and Emeson RB (2010) Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol Dis 39:169-180.
22. Nebigil CG, Etienne N, Messaddeq N, and Maroteaux L (2003) Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B receptor signaling. FASEB J 17:1373-1375.
23. Neve K (2009) Functional Selectivity of G Protein-Coupled Receptor Ligands, Humana, New York.
24. Nowak G, Aleo MD, Morgan JA, and Schnellmann RG (1998) Recovery of cellular functions following oxidant injury. Am J Physiol 274:F509-F515.
25. Nowak G and Schnellmann RG (1995) Improved culture conditions stimulate gluconeogenesis in primary cultures of renal proximal tubule cells. Am J Physiol 268:C1053-C1061.
26. Nowak G and Schnellmann RG (1996) L-ascorbic acid regulates growth and metabolism of renal cells: improvements in cell culture. Am J Physiol 271:C2072-C2080.
27. Ozbek E (2012) Induction of oxidative stress in kidney. Int J Nephrol 2012:465897.
28. Puigserver P, Wu Z, Park CW, Graves R, Wright M, and Spiegelman BM (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839.
29. Rasbach KA, Funk JA, Jayavelu T, Green PT, and Schnellmann RG (2010) 5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis. J Pharmacol Exp Ther 332:632-639.
30. Rasbach KA and Schnellmann RG (2007) PGC-1alpha over-expression promotes recovery from mitochondrial dysfunction and cell injury. Biochem Biophys Res Commun 355:734-739.
31. Rinaldi-Carmona M, Congy C, Santucci V, Simiand J, Gautret B, Neliat G, Labeeuw B, Le Fur G, Soubrie P, and Breliere JC (1992) Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist. J Pharmacol Exp Ther 262:759-768.
32. Roth BL, editor (2006) The Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics, Humana Press, Totowa, NJ.
33. Seo AY, Joseph AM, Dutta D, Hwang JC, Aris JP, and Leeuwenburgh C (2010) New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci 123:2533-2542.
34. Siuciak JA, Chapin DS, McCarthy SA, Guanowsky V, Brown J, Chiang P, Marala R, Patterson T, Seymour PA, and Swick A, et al. (2007) CP-809, 101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity. Neuropharmacology 52:279-290.
35. Smith JA, Stallons LJ, Collier JB, Chavin KD, and Schnellmann RG (2015) Suppression of mitochondrial biogenesis through toll-like receptor 4-dependent mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling in endotoxin-induced acute kidney injury. J Pharmacol Exp Ther 352:346-357.
36. Strong PV, Greenwood BN, and Fleshner M (2009) The effects of the selective 5-HT (2C) receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats. Psychopharmacology (Berl) 203:665-675.
37. Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RA, Lazarowski ER, Damian VA, Masliah E, and La Spada AR (2012) PGC-1a rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med 4:142ra97.
38. Ventura-Clapier R, Garnier A, and Veksler V (2008) Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res 79:208-217.
39. Weinberg JM, Roeser NF, Davis JA, and Venkatachalam MA (1997) Glycineprotected, hypoxic, proximal tubules develop severely compromised energetic function. Kidney Int 52:140-151.
40. Weinberg JM, Venkatachalam MA, Roeser NF, and Nissim I (2000) Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc Natl Acad Sci USA 97:2826-2831.
41. Whitaker RM, Wills LP, Stallons LJ, and Schnellmann RG (2013) cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury. J Pharmacol Exp Ther 347:626-634.
42. Wills LP, Trager RE, Beeson GC, Lindsey CC, Peterson YK, Beeson CC, and Schnellmann RG (2012) The b2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. J Pharmacol Exp Ther 342:106-118.
43. Xu J, Yao B, Fan X, Langworthy MM, Zhang MZ, and Harris RC (2007) Characterization of a putative intrarenal serotonergic system. Am J Physiol Renal Physiol 293:F1468-F1475.
44. Xu Y, Jones JE, Kohno D, Williams KW, Lee CE, Choi MJ, Anderson JG, Heisler LK, Zigman JM, and Lowell BB, et al. (2008) 5-HT2CRs expressed by proopiomelanocortin neurons regulate energy homeostasis. Neuron 60:582-589.